Ventricular CSF immunoglobulins in brain tumours.

Area of Science:

• Neuroscience
• Oncology
• Immunology

Background:

• Brain tumors can affect the composition of cerebrospinal fluid (CSF).
• Understanding CSF changes may provide insights into tumor characteristics and host response.
• The blood-brain barrier (BBB) integrity is crucial for maintaining a stable CNS environment.

Purpose of the Study:

• To investigate alterations in CSF biochemical and immunological markers in patients with brain tumors.
• To correlate CSF findings with tumor type (benign vs. malignant).
• To assess the integrity of the blood-brain barrier and the presence of a humoral immune response.

Main Methods:

• Analysis of ventricular CSF from 37 brain tumor patients.
• Measurement of CSF glucose, total protein, protein electrophoresis (albumin, gamma globulin), IgG, IgA, and IgM.
• CSF cytology was also performed.
• Comparison of marker concentrations between benign and malignant tumors.

Main Results:

• CSF glucose levels remained unchanged.
• Total protein concentration was significantly elevated.
• Protein electrophoresis showed increased albumin and gamma globulin fractions.
• Mean IgG and IgA levels were significantly higher in malignant tumors (P < 0.001).
• IgM was detectable in 7 out of 37 cases.

Conclusions:

• Elevated total protein, albumin, and gamma globulin indicate impaired blood-brain barrier function in brain tumor patients.
• Increased concentrations of IgG, IgA, and IgM suggest a localized humoral immune response within the brain against the tumors.
• CSF analysis provides valuable information regarding BBB status and immune activity in the context of brain tumors.